A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
Darcy B PoolerDylan B NessAlexey V DanilovBridget M LabrieTor D TostesonAlan EastmanLionel D LewisFrederick LansiganPublished in: EJHaem (2022)